NCT00080925
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +65 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
1,466 public trials
175 recruiting studies
Lymphoma trial results
Completed
Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma
NCT00589381
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +48 more
- Locations
-
- Childrens Hospital Los Angeles Los Angeles, California, United States
- USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States
- Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
NCT00581737
- Conditions
- Central Nervous System Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT01147991
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Digestive System Diseases, +39 more
- Locations
-
- University of Birmingham Birmingham, England, United Kingdom
- Royal Marsden - London London, England, United Kingdom
- Christie Hospital Manchester, England, United Kingdom
NCT00018954
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +31 more
- Locations
-
- Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
- National Cancer Institute of Egypt Cairo, Egypt
- Kidwai Memorial Institute of Oncology Bangalore, India
- Cancer Institute (W.I.A.) Madras, India
NCT00568815
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
NCT00854425
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
NCT00549185
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
Completed
Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL
NCT01527422
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Hospital Auxilio Mutuo Cancer Center San Juan, Puerto Rico
Completed
Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma
NCT00427765
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States